18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease.
Year: 2018
Type: article
Abstract: F-flutemetamol, has emerged as potential powerful tool for aiding AD diagnosis. The aim of the present paper is to review the existing literature on the clinical use of these new amyloid tracers in order to delineate their diagnostic value and limitations.
Source: Europe PMC (PubMed Central)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2948526931
